Market Closed - Nasdaq Stockholm 10:59:04 2024-04-29 am EDT 5-day change 1st Jan Change
198.5 SEK +1.02% Intraday chart for Stille AB +8.77% +31.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Stille AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Stille AB Omits to Pay Dividend for the Financial Year 2023 CI
Stille AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Stille Closes Purchase of Germany's Fehling Instruments MT
Stille AB (OM:STIL) acquired Fehling Instruments Gmbh & Co. Kg and Fehling Verwaltungs Gmbh. CI
Stille AB Elects Victor Steien as New Ordinary Member of the Board of Directors CI
Stille to Raise SEK425 Million to Fund Fehling Acquisition MT
Stille Strikes EUR36 Million Deal to Buy German Medical Instrument Companies MT
Stille AB (OM:STIL) entered into an agreement to acquire Fehling Instruments Gmbh & Co. Kg and Fehling Verwaltungs Gmbh for ?36 million. CI
Stille AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Stille AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Stille AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Stille AB Proposes Dividend for the Business Year 2022, Payable on May 12, 2023 CI
Stille AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Stille AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Swedish Medical Device Maker Stille Names New CEO MT
Stille AB Announces Change of CEO CI
Stille AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Stille AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Stille AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Stille AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Stille AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Stille AB Proposes Dividend for 2021 CI
Stille Selects Exclusive US Distributor Of Surgical Instruments MT
Stille AB Signs Exclusive Distribution Agreement for Surgical Instruments in US CI
Chart Stille AB
More charts
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Calendar
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. STIL Stock
  4. News Stille AB
  5. Stille Strikes EUR36 Million Deal to Buy German Medical Instrument Companies